ATAI Life Sciences B.V. Contracts & Agreements
41 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (3)
- Human Resources (14)
- Intellectual Property (3)
- Uncategorized (7)
- Separation Agreement between Mr. Stephen Bardin and atai Life Sciences N.V., dated February 6, 2024 (Filed With SEC on February 6, 2024)
- Share Purchase Deed, dated January 18, 2024, by and among the Company, Beckley Psytech Limited, and certain other persons set forth therein.1 (Filed With SEC on January 23, 2024)
- Termination and New Consultancy Agreement, by and among the Company, ATAI AG and Christian Angermayer, dated January 7, 2024 (Filed With SEC on January 9, 2024)
- Fourth Amendment to Series A Preferred Stock Purchase Agreement by and among atai Life Sciences AG, Recognify Life Sciences, Inc., f/k/a FSV7, Inc., and the Shareholders (as... (Filed With SEC on November 14, 2023)
- Amended Executive Employment Agreement, dated August 25, 2023, by and between atai Life Sciences US, Inc. and Stephen Bardin (Filed With SEC on August 31, 2023)
- Second Amendment to the Loan and Security Agreement between the Registrant, ATAI Life Sciences AG, certain of the Registrants subsidiaries from time to time party thereto as a... (Filed With SEC on May 31, 2023)
- Employment Agreement, dated November 8, 2022, by and between Stephen Bardin and atai Life Sciences AG (Filed With SEC on November 10, 2022)
- Open Market Sale Agreement, dated as of November 10, 2022, between ATAI Life Sciences N.V. and Jefferies LLC (Filed With SEC on November 10, 2022)
- Loan and Security Agreement between the Registrant, ATAI Life Sciences AG, certain of the Registrants subsidiaries from time to time party thereto as a guarantor, Hercules... (Filed With SEC on August 15, 2022)
- Executive Employment Agreement, dated June 11, 2022, by and among ATAI Life Sciences US, Inc., ATAI Life Sciences N.V. and Stephen Bardin (Filed With SEC on August 15, 2022)
- Transition and Separation Agreement, dated June 15, 2022, by and among ATAI Life Sciences US, Inc., ATAI Life Sciences N.V. and Greg Weaver (Filed With SEC on June 17, 2022)
- DESCRIPTION OF THE REGISTRANT'S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (Filed With SEC on May 16, 2022)
- Description of Securities (Filed With SEC on March 30, 2022)
- Form of Underwriting Agreement (Filed With SEC on June 11, 2021)
- Service Agreement, dated June 5, 2019, between the Registrant and Florian Brand, as amended by agreement dated June 10, 2021 (Filed With SEC on June 11, 2021)
- Amended and Restated Employment Agreement, dated June 9, 2021, between ATAI Life Sciences US, Inc. and Greg Weaver (Filed With SEC on June 11, 2021)
- Amended and Restated Employment Agreement, dated June 9, 2021, between ATAI Life Sciences US, Inc. and Srinivas Rao (Filed With SEC on June 11, 2021)
- Form of Indemnification Agreement between ATAI Life Sciences N.V. and members of the Supervisory Board or Management Board (Filed With SEC on June 11, 2021)
- 2021 Incentive Award Plan, as it will be in effect upon the effectiveness of the registration statement (Filed With SEC on June 11, 2021)
- Form of Option Award Agreement under 2021 Incentive Award Plan (Filed With SEC on June 11, 2021)
- Form of Restricted Stock Award Agreement under 2021 Incentive Award Plan (Filed With SEC on June 11, 2021)
- Form of Restricted Stock Unit Agreement under 2021 Incentive Award Plan (Filed With SEC on June 11, 2021)
- 2020 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on June 11, 2021)
- Form of Stock Option Agreement under 2020 Employee, Director and Consultant Equity Incentive Plan (Filed With SEC on June 11, 2021)
- Partnership Agreement of ATAI Life Sciences HSOP GbR, dated August 21, 2020 (Filed With SEC on June 11, 2021)
- Remuneration Policy for the Board of Supervisory Directors of ATAI Life Sciences N.V (Filed With SEC on June 11, 2021)
- Remuneration Policy for the Board of Managing Directors of ATAI Life Sciences N.V (Filed With SEC on June 11, 2021)
- Amended and Restated Employment Agreement, dated June 9, 2021 between Rolando Gutirrez Esteinou and ATAI Life Sciences US, Inc (Filed With SEC on June 11, 2021)
- Preferred Stock Purchase Agreement, dated as of August 29, 2019, between GABA Therapeutics, Inc. and ATAI Life Sciences AG, as amended by the Omnibus Amendment, dated as of... (Filed With SEC on June 4, 2021)
- Amendment to Preferred Stock Purchase Agreement, dated as of May 15, 2021 by and among ATAI Life Sciences AG, GABA Therapeutics, LLC and GABA Therapeutics, Inc (Filed With SEC on June 4, 2021)
- Series A Preferred Stock Purchase Agreement, dated as of November 6, 2020, between FSV7, Inc. and ATAI Life Sciences AG (Filed With SEC on May 27, 2021)
- License and Collaboration Agreement, dated as of March 11, 2021, between Perception Neuroscience, Inc. and Otsuka Pharmaceutical Co., Ltd (Filed With SEC on May 27, 2021)
- Stock Purchase Agreement, dated as of November 5, 2018, by and between ATAI US 2, Inc. and Jonathan Sporn (Filed With SEC on April 20, 2021)
- License Agreement, dated as of August 14, 2017, between National University Corporation Chiba University and Perception Neurosciences, Inc., as amended by Amendment No. 1, dated... (Filed With SEC on April 20, 2021)
- Stock Purchase Agreement, dated as of June 8, 2020, between The Trustees of Columbia University in the City of New York and Kures, Inc (Filed With SEC on April 20, 2021)
- Exclusive License Agreement, dated as of June 8, 2020, between The Trustees of Columbia University in the City of New York and Kures, Inc (Filed With SEC on April 20, 2021)
- Preferred Stock Purchase Agreement, dated as of August 29, 2019, between GABA Therapeutics, Inc. and ATAI Life Sciences AG, as amended by the Omnibus Amendment, dated as of... (Filed With SEC on April 20, 2021)
- Preferred Stock Purchase Agreement, dated as of December 23, 2019, among Neuronasal, Inc. and ATAI Life Sciences AG (Filed With SEC on April 20, 2021)
- Series A Preferred Stock Purchase Agreement, dated as of December 27, 2019, among DemeRx IB, Inc., ATAI Life Sciences AG and DemeRx, Inc (Filed With SEC on April 20, 2021)
- Amended and Restated License Agreement, dated as of February 21, 2020, between Allergan Sales, LLC and FSV7, LLC (Filed With SEC on April 20, 2021)
- Consultancy Agreement, dated as of January 16, 2021, between ATAI Life Sciences AG and Christian Angermayer (Filed With SEC on April 20, 2021)
